Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors

NCT06851702 · clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna